7TM Pharma has received an undisclosed milestone payment in their research collaboration within therapeutic angiogenesis with Procter & Gamble Pharmaceuticals, Inc. (P&GP), a subsidiary of The Procter & Gamble Company (NYSE: PG). The milestone was triggered by successful progress in the preclinical development of drug candidates for the treatment of diseases such as peripheral arterial diseases and coronary arterial disease related to arteriosclerosis.
